Leveraging real-world data in safety signal assessment

HIGHLIGHTS

• What: As part of TransCelerate Biopharma`s RSA-RWD Initiative, a perspective of 18 biopharmaceutical companies was provided to understand current practices and identify opportunities for use of rapid RWD analyses in safety signal assessment.
• Who: Vaishali Patadia from the Amgen, One Amgen Center Drive, Thousand Oaks, CA, USA have published the paper: Leveraging Real-World Data in Safety Signal Assessment, in the Journal: (JOURNAL) of July/28,/2022
• How: The follow-up questionnaire indicated that responding companies that use rapid RWD analyses (N=12) tend to use a minimal protocol for analyses . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.